Light Chain (AL) Amyloidosis: The Journey to Diagnosis

Patient

Volumn 11, Issue 2, 2018, Pages 207-216

  McCausland, Kristen L ^a   White, Michelle K ^a   Guthrie, Spencer D ^b   Quock, Tiffany ^b   Finkel, Muriel ^c   Lousada, Isabelle ^d   Bayliss, Martha S ^a  

^a OPTUM   (United States)

^b Prothena Biosciences Inc   (United States)

^c Amyloidosis Support Groups Inc   (United States)

^d Amyloidosis Research Consortium   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AL AMYLOIDOSIS; ANKLE EDEMA; ARTICLE; AWARENESS; BODY WEIGHT DISORDER; COMMUNITY LIVING; CONSTIPATION; DELAYED DIAGNOSIS; DIAGNOSTIC ERROR; DIARRHEA; DIFFERENTIAL DIAGNOSIS; DIZZINESS; DYSPNEA; EARLY DIAGNOSIS; EMOTION; EPIGASTRIC FULLNESS; FATIGUE; FEMALE; GASTROINTESTINAL DISEASE; HEART DISEASE; HELP SEEKING BEHAVIOR; HEMATOLOGIST; HUMAN; INTERVIEW; KIDNEY DISEASE; LEG EDEMA; LIVER DISEASE; LONGITUDINAL STUDY; MACROGLOSSIA; MAJOR CLINICAL STUDY; MALE; NEPHROLOGIST; NEUROLOGIC DISEASE; PARESTHESIA; PATIENT ADVOCACY; PERSONAL EXPERIENCE; PREVALENCE; PRIORITY JOURNAL; PURPURA; QUALITATIVE RESEARCH; QUALITY OF LIFE; QUANTITATIVE STUDY; SATIETY; SYMPTOM ASSESSMENT; THEMATIC ANALYSIS; TRIANGULATION; AGE; MIDDLE AGED; PSYCHOLOGY; TIME FACTOR;

ADULT; AGE FACTORS; AGED; EARLY DIAGNOSIS; EMOTIONS; FEMALE; HUMANS; IMMUNOGLOBULIN LIGHT-CHAIN AMYLOIDOSIS; INTERVIEWS AS TOPIC; MALE; MIDDLE AGED; TIME FACTORS;

EID: 85028573915     PISSN: 11781653     EISSN: 11781661     Source Type: Journal    
DOI: 10.1007/s40271-017-0273-5     Document Type: Article

References (14)

1. Kyle RA, Linos A, Beard CM, Linke RP, Gertz MA, O’Fallon WM, et al. Incidence and natural history of primary systemic amyloidosis in Olmsted County, Minnesota, 1950 through 1989. Blood. 1992;79(7):1817–22.
2. Pinney JH, Smith CJ, Taube JB, Lachmann HJ, Venner CP, Gibbs SD, et al. Systemic amyloidosis in England: an epidemiological study. Br J Haematol. 2013;161(4):525–32.
3. Falk RH, Comenzo RL, Skinner M. The systemic amyloidoses. N Engl J Med. 1997;337(13):898–909.
4. Merlini G, Seldin DC, Gertz MA. Amyloidosis: pathogenesis and new therapeutic options. J Clin Oncol. 2011;29(14):1924–33.
5. Palladini G, Lavatelli F, Russo P, Perlini S, Perfetti V, Bosoni T, et al. Circulating amyloidogenic free light chains and serum N-terminal natriuretic peptide type B decrease simultaneously in association with improvement of survival in AL. Blood. 2006;107(10):3854–8.
6. Kyle RA, Gertz MA. Primary systemic amyloidosis: clinical and laboratory features in 474 cases. Semin Hematol. 1995;32:45–59.
7. Gertz MA. Immunoglobulin light chain amyloidosis: 2013 update on diagnosis, prognosis, and treatment. Am J Hematol. 2013;88(5):416–25.
8. Sanchorawala V. Light-chain (AL) amyloidosis: diagnosis and treatment. Clin J Am Soc Nephrol. 2006;1:1331–41.
9. Palladini G, Milani P, Foli A, Obici L, Lavatelli F, Nuvolone M, et al. Oral melphalan and dexamethasone grants extended survival with minimal toxicity in AL amyloidosis: long-term results of a risk-adapted approach. Haematologica. 2014;99(4):743–50.
10. Sayago I, Krsnik I, Gómez-Bueno M, García-Pavía P, Jaramillo N, Salas C, et al. Analysis of diagnostic and therapeutic strategies in advanced cardiac light-chain amyloidosis. J Heart Lung Transplant. 2016;35(8):995–1002.
11. Creswell JW, Plano Clark VL. Designing and conducting mixed methods research. 2nd ed. Thousand Oaks: Sage; 2011.
12. Strauss AL, Corbin JM. Basics of qualitative research: grounded theory procedures and techniques. Newbury Park: Sage Publications; 1990.
13. Merlini G, Wechalekar AD, Palladini G. Systemic light chain amyloidosis: an update for treating physicians. Blood. 2013;121(26):5124–30.
14. Colucci G, Alberio L, Demarmels Biasiutti F, Lämmle B. Bilateral periorbital ecchymoses. An often missed sign of amyloid purpura. Hamostaseologie. 2014;34(3):249–52.